Learning Objectives:

  1. Be able to state the definitions of polypharmacy and deprescribing.
  2. Identify risk factors for polypharmacy
  3. Understand potential consequences of polypharmacy.
  4. Learn strategies to assist with decision making regarding deprescribing.


Session date: 
11/08/2019 - 8:30am to 9:00am CST
Little Company of Mary Hospital
United States
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation

Please login or create an account to proceed.
Speaker Name: 
Lisa Peters